8月12日，Core Scientific盘中上涨9.11%，报21.16美元/股，成交额3085.13万美元。消息面上，该股此前连续下挫（8月10日跌5.05%，随后再跌7.47%至19.44美元），短期超跌后技术性反弹需求强烈；同板块个股IREN同日涨8.19%、Riot Platforms涨3.19%，行业整体回暖带动资金回流。
此外，B. Riley此前将目标价由33美元大幅上调至42美元并维持买入评级，Keefe Bruyette亦将评级上调至跑赢大盘、目标价调至28美元，为股价提供估值锚定支撑。不过公司Q2每股亏损3.32美元远超预期，叠加AMD合作附带的认股权证稀释担忧仍构成压制因素，反弹持续性有待观察。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.